These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33667709)

  • 1. Identification of a novel protective human monoclonal antibody, LXY8, that targets the key neutralizing epitopes of staphylococcal enterotoxin B.
    Hu N; Qiao C; Wang J; Wang Z; Li X; Zhou L; Wu J; Zhang D; Feng J; Shen B; Zhang J; Luo L
    Biochem Biophys Res Commun; 2021 Apr; 549():120-127. PubMed ID: 33667709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
    Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site.
    Xia T; Liang S; Wang H; Hu S; Sun Y; Yu X; Han J; Li J; Guo S; Dai J; Lou Z; Guo Y
    MAbs; 2014; 6(1):119-29. PubMed ID: 24423621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies.
    Tilahun ME; Rajagopalan G; Shah-Mahoney N; Lawlor RG; Tilahun AY; Xie C; Natarajan K; Margulies DH; Ratner DI; Osborne BA; Goldsby RA
    Infect Immun; 2010 Jun; 78(6):2801-11. PubMed ID: 20308304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.
    Varshney AK; Wang X; Cook E; Dutta K; Scharff MD; Goger MJ; Fries BC
    J Biol Chem; 2011 Mar; 286(11):9737-47. PubMed ID: 21233204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptides.
    Zhao Z; Li B; Sun HQ; Zhang JY; Wang YL; Chen L; Hu J; He YF; Zeng H; Zou QM; Wu C
    PLoS One; 2014; 9(3):e90445. PubMed ID: 24599257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Neutralization of Staphylococcal Enterotoxin B In Vivo by Antibodies that Block Binding to the T-Cell Receptor.
    Chen G; Karauzum H; Long H; Carranza D; Holtsberg FW; Howell KA; Abaandou L; Zhang B; Jarvik N; Ye W; Liao GC; Gross ML; Leung DW; Amarasinghe GK; Aman MJ; Sidhu SS
    J Mol Biol; 2019 Oct; 431(21):4354-4367. PubMed ID: 30928493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
    Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
    PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
    Hamad AR; Herman A; Marrack P; Kappler JW
    J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.
    Liu Y; Song Z; Ge S; Zhang J; Xu L; Yang F; Lu D; Luo P; Gu J; Zou Q; Zeng H
    Hum Vaccin Immunother; 2020 Jul; 16(7):1708-1718. PubMed ID: 32275466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.
    Larkin EA; Stiles BG; Ulrich RG
    PLoS One; 2010 Oct; 5(10):e13253. PubMed ID: 20949003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.
    Karauzum H; Chen G; Abaandou L; Mahmoudieh M; Boroun AR; Shulenin S; Devi VS; Stavale E; Warfield KL; Zeitlin L; Roy CJ; Sidhu SS; Aman MJ
    J Biol Chem; 2012 Jul; 287(30):25203-15. PubMed ID: 22645125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Construction of a Single-Chain Bi-Paratopic Antibody Allosterically Inhibiting TCR-Staphylococcal Enterotoxin B Binding.
    Bai G; Ge Y; Su Y; Chen S; Zeng X; Lu H; Ma B
    Front Immunol; 2021; 12():732938. PubMed ID: 34887850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Fab fragment-like molecular recognition proteins against staphylococcal enterotoxin B by phage display technology.
    Urushibata Y; Itoh K; Ohshima M; Seto Y
    Clin Vaccine Immunol; 2010 Nov; 17(11):1708-17. PubMed ID: 20844088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
    Woody MA; Krakauer T; Stiles BG
    Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.
    Varshney AK; Wang X; Aguilar JL; Scharff MD; Fries BC
    mBio; 2014 Jun; 5(3):e01007-14. PubMed ID: 24917594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.